AGP Picks
View all

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on October 15, 2026

CTW Announces Fiscal Year 2026 Financial Results
Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors
Waldencast plc Files Form 15 to Deregister its Securities and Suspend its SEC Reporting Obligations under the Exchange Act
Asure Software to Announce Third Quarter 2026 Financial Results on October 29, 2026
Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC…
Proofpoint to Acquire Varonis in a $6.3 Billion Transaction
Bombardier Solidifies Commitment to Kansas by Growing Site Capabilities Through $50 Million of Investments
Bombardier renforce son engagement envers le Kansas en augmentant les capacités de son site grâce à des investissements de 50 millions de dollars
SPS Commerce Announces Date of Third Quarter 2026 Financial Results
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
Brilliant Earth to Report Third Quarter 2026 Financial Results on November 5th
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
LB Pharmaceuticals to Participate in Upcoming Investor Events
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
Vertex to Announce Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
STACK Celebrates Inaugural Critical Operations Development Academy Graduating Class in Santa Teresa, New Mexico
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.